Daptomycin and myopathy
WebDec 11, 2024 · Daptomycin is associated with an increased incidence of myopathy and rhabdomyolysis. There have been cases reported in …
Daptomycin and myopathy
Did you know?
WebDaptomycin for Injection is not indicated for the treatment of pneumonia. Daptomycin for Injection is not indicated for the treatment of left-sided infective endocarditis due to . S. … WebNov 24, 2024 · Daptomycin is a lipopeptide antibiotic that is active against vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA). It is less nephrotoxic than vancomycin. …
WebDaptomycin can cause skeletal muscle myopathy with elevations in CPK. The percentage of patients treated with daptomycin in phase III trials who experienced … WebDaptomycin is given parenterally once a day. Over 90% is bound to serum protein. Dosing is adjusted for renal failure. Because daptomycin can cause reversible skeletal …
WebSimvastatin is contraindicated in the following conditions: Concomitant use of strong CYP3A4 inhibitors (select azole anti-fungals, macrolide antibiotics, anti-viral medications, and nefazodone ... 5 WARNINGS AND PRECAUTIONS 5.1 Myopathy and Rhabdomyolysis - Simvastatin may cause myopathy and rhabdomyolysis. WebApr 1, 2005 · We conclude that daptomycin was the likely cause of our patient's myopathy and possible hepatotoxicity. To our knowledge, this is the only case of daptomycin myopathy with associated liver function abnormalities.
WebOct 12, 2024 · Atorvastatin, rosuvastatin, and simvastatin all increased the incidence of DAP-related myopathy and rhabdomyolysis. Conclusion: The mixed approach combining a meta-analysis and disproportionality analysis showed that statin use was associated with the occurrence of DAP-related rhabdomyolysis.
WebJun 6, 2024 · Daptomycin 500mg Powder for Solution for Injection/ Infusion Active Ingredient: daptomycin Company: Panpharma UK Ltd See contact details ATC code: J01XX09 About Medicine Prescription only medicine Healthcare Professionals (SmPC) Patient Leaflet (PIL) This information is for use by healthcare professionals Last updated … c# static empty listWebDaptomycin myopathy might be dose or frequency related. In phase 1 trials, two out of five patients developed clinically significant myopathy with myalgias and CK elevation when used at 4 mg/kg/q12 hours . This happened less frequently in further studies using a 4 mg/kg/q24 hours dosage. Of 534 patients in a study receiving daptomycin, only 11 ... early data assessmentWebFeb 28, 2024 · A drug-induced myopathy is defined as the manifestation of myopathic symptoms occurring in patients without prior muscle disease when exposed to … early dataWebDaptomycin is given parenterally once a day. Over 90% is bound to serum protein. Dosing is adjusted for renal failure. Because daptomycin can cause reversible skeletal myopathy, patients should be monitored for muscle pain or weakness, and serum creatine kinase levels should be checked weekly. early data was not sentWebMyopathy type: Necrotizing Drugs: Chlorphenteramine; Chlorcyclizine; Triparanol; Iprindol; 20,25-Diazacholesterol, Local anesthetics Drug features Highest lipid solubility & high pH in solution Hydrophobic region partitions into membranes Myopathy type: Vacuolar Drugs Chloroquine ; Hydroxychloroquine; Doxorubicin; Perhexiline & Amiodarone early database designerWebDaptomycin is a lipopeptide antibacterial with a spectrum of activity similar to vancomycin but its efficacy against enterococci has not been established. It needs to be given with … early danceWebOct 10, 2024 · Daptomycin (DAP) is a cyclic lipopeptide antibiotic widely used for patients with methicillin-resistant Staphylococcus aureus infection [1, 2].DAP increases the risk of elevated creatine phosphokinase (CPK) caused by muscle injury, leading to myopathy and rhabdomyolysis in 2%–13% and 5% of the patients, respectively [].Therefore, weekly … early dan later experience